Delek US (NYSE:DK) Rating Increased to Buy at Wall Street Zen

Delek US (NYSE:DK) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.

Several other analysts have also weighed in on the stock. UBS Group boosted their target price on shares of Delek US from $31.00 to $42.00 and gave the company a “neutral” rating in a research note on Tuesday, November 18th. Wells Fargo & Company raised their price target on shares of Delek US from $43.00 to $53.00 and gave the stock an “overweight” rating in a research report on Monday, November 10th. Citigroup decreased their price target on shares of Delek US from $37.00 to $33.00 and set a “neutral” rating for the company in a report on Monday, January 26th. TD Cowen boosted their price objective on shares of Delek US from $28.00 to $44.00 and gave the company a “hold” rating in a research report on Thursday. Finally, Mizuho increased their price objective on shares of Delek US from $45.00 to $51.00 and gave the stock an “outperform” rating in a research note on Friday, December 12th. Four equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $39.46.

Delek US Stock Performance

Shares of DK stock opened at $42.35 on Friday. The stock has a market capitalization of $2.54 billion, a price-to-earnings ratio of -121.00 and a beta of 0.75. Delek US has a one year low of $11.02 and a one year high of $45.74. The company’s 50-day simple moving average is $32.38 and its 200-day simple moving average is $33.31. The company has a debt-to-equity ratio of 5.89, a quick ratio of 0.58 and a current ratio of 0.82.

Delek US (NYSE:DK) last issued its quarterly earnings results on Friday, February 27th. The oil and gas company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.63. The business had revenue of $2.43 billion during the quarter, compared to the consensus estimate of $2.55 billion. Delek US had a negative return on equity of 13.55% and a negative net margin of 0.21%.The business’s quarterly revenue was up 2.3% on a year-over-year basis. During the same period in the previous year, the business earned ($2.54) EPS. Equities analysts anticipate that Delek US will post -5.5 earnings per share for the current fiscal year.

Insider Activity at Delek US

In other news, Director Shlomo Zohar sold 22,029 shares of the company’s stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $44.83, for a total value of $987,560.07. Following the completion of the sale, the director directly owned 18,989 shares of the company’s stock, valued at approximately $851,276.87. This represents a 53.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Avigal Soreq sold 50,000 shares of the business’s stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $41.08, for a total value of $2,054,000.00. Following the completion of the sale, the chief executive officer directly owned 251,678 shares in the company, valued at $10,338,932.24. This represents a 16.57% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 142,764 shares of company stock worth $5,989,317 in the last three months. Insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Delek US

Institutional investors and hedge funds have recently bought and sold shares of the business. Brown Brothers Harriman & Co. bought a new position in shares of Delek US during the 3rd quarter valued at about $27,000. Caitong International Asset Management Co. Ltd grew its stake in shares of Delek US by 95.6% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 884 shares of the oil and gas company’s stock worth $26,000 after purchasing an additional 432 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Delek US by 173.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 968 shares of the oil and gas company’s stock worth $29,000 after purchasing an additional 614 shares in the last quarter. Torren Management LLC acquired a new stake in Delek US during the fourth quarter valued at approximately $40,000. Finally, Focus Partners Wealth acquired a new stake in Delek US during the third quarter valued at approximately $44,000. 97.01% of the stock is owned by institutional investors and hedge funds.

Delek US News Roundup

Here are the key news stories impacting Delek US this week:

• Positive Sentiment: TD Cowen raised its price target from $28 to $44 (hold), narrowing upside uncertainty and signaling improving analyst visibility. Finviz
• Positive Sentiment: Quarterly results: Delek US reported a surprise EPS beat ($0.44 vs. est. -$0.19), which is supportive for the shares despite a slight revenue shortfall. (Source: company/market coverage)
• Positive Sentiment: Dividend declared: a $0.255 quarterly dividend (annualized $1.02, ~2.3% yield) payable March 9 — offers short-term income support for the stock.
• Neutral Sentiment: Institutional activity: several large funds have adjusted positions recently (mix of increases and new stakes); institutional ownership remains high (~97%), which can both stabilize and concentrate stock moves.
• Negative Sentiment: CEO sale: CEO Avigal Soreq sold 50,000 shares (~$2.05M at ~$41.08). Large insider sales from the CEO often trigger investor concern about timing and outlook. CEO Sale — SEC filing: Form 4
• Negative Sentiment: Additional insider selling: multiple executives and directors sold sizable stakes in early March (EVPs Reuven Spiegel — 20,000 sh; Joseph Israel — 38,000 sh; Directors Shlomo Zohar and William Finnerty also sold). The cluster of senior-level sales is adding downward pressure. Relevant SEC filings: Spiegel (Read More.), Israel (Read More.), Zohar (Read More.), Finnerty (Read More.).
• Negative Sentiment: Analyst moves mixed-to-negative: Citi and Piper Sandler trimmed price targets (to $33 and $40 respectively) and Weiss reiterated a sell — these downward revisions amplify selling pressure even as some shops (e.g., Mizuho) remain bullish.

About Delek US

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.